Literature DB >> 26544112

Recent Court Ruling in Japan Exemplifies Another Layer of Regulation for Regenerative Therapy.

Tsunakuni Ikka1, Misao Fujita2, Yoshimi Yashiro3, Hiroshi Ikegaya4.   

Abstract

Mesh：

Year:  2015        PMID： 26544112     DOI： 10.1016/j.stem.2015.10.008

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  5 in total

Review 1.  Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions.

Authors:  Gerhard Bauer; Magdi Elsallab; Mohamed Abou-El-Enein
Journal:  Stem Cells Transl Med       Date:  2018-07-31       Impact factor: 6.940

2.  Financial risks posed by unproven cell interventions: Estimation of refunds from medical expense deductions in Japan.

Authors:  Taichi Hatta; Kazuki Ide; Misao Fujita; Tsunakuni Ikka
Journal:  Stem Cell Reports       Date:  2022-04-21       Impact factor: 7.294

3.  A comparative analysis of attitudes toward stem cell research and regenerative medicine between six countries - A pilot study.

Authors:  Ryuma Shineha; Yusuke Inoue; Yoshimi Yashiro
Journal:  Regen Ther       Date:  2022-05-13       Impact factor: 3.651

4.  A Comparative Analysis of Attitudes on Communication Toward Stem Cell Research and Regenerative Medicine Between the Public and the Scientific Community.

Authors:  Ryuma Shineha; Yusuke Inoue; Tsunakuni Ikka; Atsuo Kishimoto; Yoshimi Yashiro
Journal:  Stem Cells Transl Med       Date:  2018-01-26       Impact factor: 6.940

Review 5.  Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions.

Authors:  Claire Horner; Evelyn Tenenbaum; Douglas Sipp; Zubin Master
Journal:  NPJ Regen Med       Date:  2018-02-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.